Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Poly-L-lactic acid: an overview.

Pahala Simamora1, Wendy Chern

  • 1Sanofi-Aventis, Berwyn, PA 19312, USA. Pahala.Simamora@sanofi-aventis.com

Journal of Drugs in Dermatology : JDD
|May 18, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decoding Oligonucleotide Stereochemistry: Individual Phosphorothioate Configuration Ratios and Intact Sequence Diastereomeric Composition.

Analytical chemistry·2026
Same author

A novel 0.5% fluorouracil cream is minimally absorbed into the systemic circulation yet is as effective as 5% fluorouracil cream.

Cutis·2002
Same author

Review on the systemic delivery of insulin via the ocular route.

International journal of pharmaceutics·2002
Same journal

Pigmented Basal Cell Carcinoma in Skin of Color: A Systematic Review of the Literature.

Journal of drugs in dermatology : JDD·2026
Same journal

Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients.

Journal of drugs in dermatology : JDD·2026
Same journal

Efficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Postinflammatory Hyperpigmentation.

Journal of drugs in dermatology : JDD·2026
Same journal

Decoding Sensitive Skin Syndrome: International Expert Advisory Insights on Management From India and the United States of America.

Journal of drugs in dermatology : JDD·2026
Same journal

Evaluating the Safety and Efficacy of Sirolimus Topical Gel 0.2% to Treat Acanthosis Nigricans.

Journal of drugs in dermatology : JDD·2026
Same journal

Moringa-Derived Formulations for Hair Growth, Hair Preservation, and Hair Loss: A Systematic Review.

Journal of drugs in dermatology : JDD·2026
See all related articles

Poly-L-lactic acid (PLLA) injectable devices, approved for facial lipoatrophy in HIV patients, stimulate new collagen growth. These PLLA microparticles are safely metabolized and cleared by the body.

Area of Science:

  • Biomaterials Science
  • Dermatology
  • Medical Device Technology

Background:

  • Poly-L-lactic acid (PLLA) is a biodegradable, biocompatible synthetic polymer with a history of safe medical applications.
  • PLLA-based injectable devices are used for facial fat loss correction in HIV patients.
  • The mechanism of PLLA microparticles in tissue regeneration is of significant medical interest.

Purpose of the Study:

  • To review the properties and mechanism of action of poly-L-lactic acid (PLLA) microparticles used in cosmetic and reconstructive procedures.
  • To understand the neocollagenesis process initiated by PLLA in response to a foreign-body reaction.

Main Methods:

  • Review of existing literature on PLLA microparticles and their medical applications.
  • Analysis of the biological response to PLLA microparticles, including neocollagenesis and biodegradation.

Related Experiment Videos

  • Examination of the metabolic pathway and clearance of PLLA in the body.

    • Main Results:

    • PLLA microparticles are approved for correcting facial lipoatrophy in HIV-positive individuals.
    • PLLA initiates neocollagenesis, leading to volume restoration through collagen deposition.
    • The PLLA material is safely metabolized into carbon dioxide and water, which are then expelled by the body.

    Conclusions:

    • PLLA microparticles are effective and safe for facial volume restoration.
    • The mechanism involves stimulating the body's natural collagen production.
    • PLLA offers a biodegradable and biocompatible solution for soft-tissue augmentation.